Hot PPI (+0.7% MoM) and a hawkish FOMC dot plot slam markets — S&P -1.36%, Dow -768 pts. WTI crude near $100 as Strait of Hormuz enters week three; Moody’s raises US recession odds to 49%. AbbVie -5.20% as J&J wins FDA approval for competing oral psoriasis drug. Mastercard -3.57% on $1.8B stablecoin BVNK acquisition. Micron (MU) reports record Q2 revenue of $23.86B AMC (+196% YoY); markets react Thursday.
Tag Archives | Johnson & Johnson
MIB: Stagflation Trap — Hot PPI, Hawkish Fed, and $100 Oil Push Recession Odds to 49%
Read full story · Comments are closed
MIB: FOMC Day One, Oil Resumes Rally, Amazon’s $600B AI Bet, and a Brutal LLY Downgrade
Oil resumed its climb — WTI $96, Brent $103+ — as FOMC Day 1 began and Monday’s de-escalation optimism faded. Amazon CEO Jassy doubled AWS 10-year target to $600B on AI demand (AMZN +1%). HSBC issued a rare Sell on LLY (-5.3%) citing GLP-1 market TAM saturation and imminent price wars. February retail sales beat (+0.6%) showed the consumer holding firm. Delta (DAL +6%) and American (AAL +4%) lifted Q1 guidance — travel demand crushing oil cost headwinds.
Read full story · Comments are closed
